Effects of varying degrees of intermittent hypoxia on proinflammatory cytokines and adipokines in rats and 3T3-L1 adipocytes

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  He, Qing ^a   Yang, Qing Chan ^a   Zhou, Qin ^a   Zhu, Hui ^a   Niu, Wen Yan ^a   Feng, Jing ^a   Wang, Yan ^a   Cao, Jie ^a   Chen, Bao Yuan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CYTOKINE; DNA BINDING PROTEIN; GLUCOSE; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 6; LEPTIN; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; BLOOD LEVEL; BODY WEIGHT; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE SEVERITY; GEL MOBILITY SHIFT ASSAY; INTERMITTENT HYPOXIA; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PH MEASUREMENT; PROTEIN DETERMINATION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RNA TRANSCRIPTION; SYNDROME DELINEATION;

ADIPOCYTES; ADIPOKINES; ADIPONECTIN; ANIMALS; ANOXIA; BLOOD GLUCOSE; CYTOKINES; GLUCOSE TRANSPORTER TYPE 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-6; LEPTIN; MODELS, ANIMAL; NF-KAPPA B; OXIDATIVE STRESS; OXYGEN; RATS; SLEEP APNEA, OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84900414616     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0086326     Document Type: Article

References (70)

1. Feng J, Chen BY (2009) Prevalence and incidence of hypertension in obstructive sleep apnea patients and the relationship between obstructive sleep apnea and its confounders. Chin Med J (Engl) 122: 1464-1468.
2. Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165: 1217-1239. (Pubitemid 34461732)
3. National Heart, Lung, and Blood Institute Working Group on Sleep Apnea (1996) Sleep apnea: is your patient at risk? Am Fam Physician 53: 247-253.
4. Lumeng JC, Chervin RD (2008) Epidemiology of pediatric obstructive sleep apnea. Proc Am Thorac Soc 5: 242-252. (Pubitemid 351237884)
5. Lavie L (2009) Oxidative stress-a unifying paradigm in obstructive sleep apnea and comorbidities. Prog Cardiovasc Dis. 51: 303-312.
6. Lévy P, Bonsignore MR, Eckel J (2009) Sleep, sleep-disordered breathing and metabolic consequences. Eur Respir J 34: 243-260.
7. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, et al. (2004) Sleepdis-ordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160: 521-530. (Pubitemid 39215628)
8. Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP (2004) Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25: 735-741. (Pubitemid 38647933)
9. Hargens TA, Guill SG, Kaleth AS, Nickols-Richardson SM, Miller LE, et al. (2013) Insulin resistance and adipose-derived hormones in young men with untreated obstructive sleep apnea. Sleep Breath 17: 403-409.
10. Polotsky VY, Li J, Punjabi NM, Rubin AE, Smith PL, et al. (2003) Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 552: 253-264. (Pubitemid 37265483)
11. Magalang UJ, Cruff JP, Rajappan R, Hunter MG, Patel T, et al. (2009) Intermittent hypoxia suppresses adiponectin secretion by adipocytes. Exp Clin Endocrinol Diabetes 117: 129-134.
12. Feng J, Chen BY, Cui LY, Wang BL, Liu CX, et al. (2009) Inflammation status of rabbit carotid artery model endothelium during intermittent hypoxia exposure and its relationship with leptin. Sleep Breath 13: 277-283.
13. Gilmartin GS, Lynch M, Tamisier R, Weiss JW (2010) Chronic intermittent hypoxia in humans during 28 nights results in blood pressure elevation and increased muscle sympathetic nerve activity. Am J Physiol Heart Circ Physiol 299: H925-931.
14. Lavie L, Polotsky V (2009) Cardiovascular aspects in obstructive sleep apnea syndrome - molecular issues, hypoxia and cytokine profiles. Respiration 78: 361-370.
15. Louis M, Punjabi NM (2009) Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol 106: 1538-1544.
16. Punjabi NM, Beamer BA (2009) Alterations in Glucose Disposal in Sleep-disordered Breathing. Am J Respir Crit Care Med 179: 235-240.
17. Reinke C, Bevans-Fonti S, Drager LF, Shin MK, Polotsky VY (2011) Effects of different acute hypoxic regimens on tissue oxygen profiles and metabolic outcomes. J Appl Physiol 111: 881-890.
18. Drager LF, Jun JC, Polotsky VY (2010) Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea. Best Pract Res Clin Endocrinol Metab 24: 843-851.
19. Li J, Thorne LN, Punjabi NM, Sun CK, Schwartz AR, et al. (2005) Intermittent hypoxia induces hyperlipidemia in lean mice. Circ Res 97: 698-706. (Pubitemid 41416339)
20. Lesser DJ, Bhatia R, Tran WH, Oliveira F, Ortega R, et al. (2012) Sleep fragmentation and intermittent hypoxemia are associated with decreased insulin sensitivity in obese adolescent Latino males. Pediatr Res 72: 293-298.
21. Pallayova M, Lazurova I, Donic V (2011) Hypoxic damage to pancreatic beta cells - the hidden link between sleep apnea and diabetes. Med Hypotheses 77: 930-934.
22. Rosen ED, Spiegelman BM (2006) Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444: 847-853. (Pubitemid 46024991)
23. Sartipy P, Loskutoff DJ (2003) Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 100: 7265-7270. (Pubitemid 36706427)
24. Bonsignore MR (2009) Eckel J. ERS Meeting Report, Metabolic aspects of obstructive sleep apnoea syndrome. Eur Respir Rev 18: 113-124.
25. Snyder EM, Carr RD, Deacon CF, Johnson BD (2008) Overnight hypoxic exposure and glucagon-like peptide-1 and leptin levels in humans. Appl Physiol Nutr Metab 33: 929-935.
26. Lam JC, Mak JC, Ip MS (2012) Obesity, obstructive sleep apnoea and metabolic syndrome. Respirology 17: 223-236.
27. Brennan AM, Mantzoros CS (2006) Drug Insight: the role of leptin in human physiology and pathophysiology-emerging clinical applications. Nat Clin Pract Endocrinol Metab 2: 318-327. (Pubitemid 43885911)
28. Díez JJ, Iglesias P (2003) The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148: 293-300. (Pubitemid 36410714)
29. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG; NC3Rs Reporting Guidelines Working Group (2010) Animal research: reporting in vivo experiments: the ARRIVE guidelines. J Gene Med 12: 561-3.
30. NC3Rs Reporting Guidelines Working Group (2010) Animal research: reporting in vivo experiments: the ARRIVE guidelines. Exp Physiol 95: 842-4.
31. Feng J, Chiang AA, Wu Q, Chen BY, Cui LY et al. (2010) Sleep-related hypoxemia aggravates systematic inflammation in emphysematous rats. Chin Med J (Engl) 123: 2392-2399.
32. Feng J, Wang QS, Chiang A, Chen BY (2010) The effects of sleep hypoxia on coagulant factors and hepatic inflammation in emphysematous rats. PLoS One 5.
33. Bruckbauer A, Zemel MB, Thorpe T, Akula MR, Stuckey AC, et al. (2012) Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond) 9: 77.
34. Yuan G, Khan SA, Luo W, Nanduri J, Semenza GL, et al. (2011) Hypoxia-inducible factor 1 mediates increased expression of NADPH oxidase-2 in response to intermittent hypoxia. J Cell Physiol 226: 2925-2933.
35. Ota H, Tamaki S, Itaya-Hironaka A, Yamauchi A, Sakuramoto-Tsuchida S, et al. (2012) Attenuation of glucose-induced insulin secretion by intermittent hypoxia via down-regulation of CD38. Life Sci 90: 206-211.
36. Marx N, Duez H, Fruchart JC, Staels B (2004) Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells. Circ Res 94: 1168-1178. (Pubitemid 38656403)
37. Kamata H, Honda S, Maeda S, Chang L, Hirata H, et al. (2005) Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120: 649-661. (Pubitemid 40343077)
38. Houstis N, Rosen ED, Lander ES (2006) Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440: 944-948.
39. Yang J, Park Y, Zhang H, Xu X, Laine GA, et al. (2009) Feed-forward signaling of TNF-alpha and NF-kappaB via IKK-beta pathway contributes to insulin resistance and coronary arteriolar dysfunction in type 2 diabetic mice. Am J Physiol Heart Circ Physiol 296: H1850-858.
40. Gao Z, Hwang D, Bataille F, Lefevre M, David Y, et al. (2002) Serine Phosphorylation of Insulin Receptor Substrate 1 by IKK complex. Journal of Biological Chemistry 277: 48115-48121.
41. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, et al. (2000) Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85: 1151-1158. (Pubitemid 32269364)
42. Delarue J, Magnan C (2007) Free fatty acids and insulin resistance. Curr Opin Clin Nutr Metab Care 10: 142-148. (Pubitemid 46220305)
43. Jun J, Polotsky VY (2007) Sleep Disordered Breathing and Metabolic Effects: Evidence from Animal Models. Sleep Med Clin 2: 263-277.
44. Yokoe T, Alonso LC, Romano LC, Rosa TC, O'Doherty RM, et al. (2008) Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice. J Physiol 586: 899-911. (Pubitemid 351194126)
45. Morton NM (2010) Obesity and corticosteroids: 11beta-hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease. Mol Cell Endocrinol 316: 154-164.
46. Toffoli S, Roegiers A, Feron O, Van Steenbrugge M, Ninane N, et al. (2009) Intermittent hypoxia is an angiogenic inducer for endothelial cells: role of HIF-1. Angiogenesis 12: 47-67.
47. McNicholas WT (2009) Obstructive sleep apnea and inflammation. Prog Cardiovasc Dis 51: 392-399.
48. Wang B, Wood IS, Trayhurn P (2007) Dysregulation of the expression and secretion of inflammation-related adipokines by hypoxia in human adipocytes. Pflugers Arch 455: 479-492. (Pubitemid 47624196)
49. Chen L, Cao ZL, Han F, Gao ZC, He QY (2010) Chronic intermittent hypoxia from pedo-stage decreases glucose transporter 4 expression in adipose tissue and causes insulin resistance. Chin Med J (Engl) 123: 463-470.
50. Grisouard J, Timper K, Radimerski TM, Frey DM, Peterli R, et al. (2010) Mechanisms of metformin action on glucose transport and metabolism in human adipocytes. Biochem Pharmacol 80: 1736-1745.
51. Cooper C, Liu GY, Niu YL, Santos S, Murphy LC, et al. (2004) Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma. Clin Cancer Res 10: 8720-8727. (Pubitemid 40053441)
52. Li S, Qian XH, Zhou W, Zhang Y, Feng J, et al. (2011) Time-dependent inflammatory factor production and NF-kB activation in a rodent model of intermittent hypoxia. Swiss Med Wkly 141: w13309.
53. Yamauchi M, Tamaki S, Tomoda K, Yoshikawa M, Fukuoka A, et al. (2006) Evidence for activation of nuclear factor kappaB in obstructive sleep apnea. Sleep Breath 10: 189-193. (Pubitemid 44768845)
54. Schofield CJ, Ratcliffe PJ (2004) Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5: 343-354. (Pubitemid 38579472)
55. Feng J, Chen BY, Guo MN, Cao J, Zhao HY, et al. (2007) [Interleukin-6 and tumor necrosis factor-alpha levels of endothelial cells in different hypoxia modes: in vitro experiment]. Zhonghua Yi Xue Za Zhi 87: 774-777.
56. Feng J, Chen BY, Guo MN, Cao J, Zhao HY, et al. (2007) [Changes of nuclear factor-kappaB and intercellular adhesion molecule-1 in endothelial cells exposed to various intermittent hypoxia]. Zhonghua Jie He He Hu Xi Za Zhi 30: 202-206.
57. Han Q, Yeung SC, Ip MS, Mak JC (2013) Intermittent hypoxia-induced NF-κB and HO-1 regulation in human endothelial EA.hy926 cells. Cell Biochem Biophys 66: 431-41.
58. Li Q, Verma IM (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734.
59. Rosa Neto JC, Lira FS, Venancio DP, Cunha CA, Oyama LM, et al. (2010) Sleep deprivation affects inflammatory marker expression in adipose tissue. Lipids Health Dis 9: 125.
60. Fouillioux C, Contreras F, Lares M, Cano R, Leal E, et al. (2008) Metabolic and hemodynamic markers of endothelial dysfunction in patients with hypertension and patients with type 2 diabetes during the cold pressor test. Am J Ther 15: 389-396.
61. Arnardottir ES, Mackiewicz M, Gislason T, Teff KL, Pack AI (2009) Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep 32: 447-470.
62. Yang R, Sikka G, Larson J, Watts VL, Niu X, et al. (2011) Restoring leptin signaling reduces hyperlipidemia and improves vascular stiffness induced by chronic intermittent hypoxia. Am J Physiol Heart Circ Physiol 300: H1467-1476.
63. Li J, Bosch-Marce M, Nanayakkara A, Savransky V, Fried SK, et al. (2006) Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia-inducible factor-1alpha. Physiol Genomics 25: 450-457. (Pubitemid 43764766)
64. Zhang XF, Wang YH, Li Q, Zhang XL, Shen JC, et al. (2010) Changes in genioglossus and their association with serum adiponectin levels in rats subjected to chronic intermittent hypoxia. Chin Med J (Engl) 123: 2249-2253.
65. Pittas AG, Joseph NA, Greenberg AS (2004) Adipocytokines and insulin resistance. J Clin Endocrinol Metab 89: 447-452. (Pubitemid 38269842)
66. Lam JC, Xu A, Tam S, Khong PI, Yao TJ, et al. (2008) Hypoadiponectinemia is related to sympathetic activation and severity of obstructive sleep apnea. Sleep 31: 1721-1727.
67. Wolk R, Svatikova A, Nelson CA, Gami AS, Govender K, et al. (2005) Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea. Obes Res 13: 186-190.
68. de Lima AM, Franco CM, de Castro CM, Bezerra Ade A, Ataíde L Jr, et al. (2010) Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea. Respiration 79: 37370-6.
69. Gao Z, He Q, Peng B, Chiao PJ, Ye J (2006) Regulation of nuclear translocation of HDAC3 by IkappaBalpha is required for tumor necrosis factor inhibition of peroxisome proliferator-activated receptor gamma function. J Biol Chem 281: 4540-4547. (Pubitemid 43847886)
70. Carter R 3rd, Watenpaugh DE (2008) Obesity and obstructive sleep apnea: or is it OSA and obesity? Pathophysiology 15: 71-77.